Rocket Pharmaceuticals Inc (RCKT)
Stock-Based Compensation
$31.78M
TTM · Period ending: · USD
RCKT Stock-Based Compensation
Latest reported$31.78Mperiod ending
Latest reported$31.78Mperiod ending
RCKT TTM Stock-Based Comp ($0.00 → $31.78M)
TTM stock-based compensation
High-resolution chart · PNG
RCKT stock-based compensation history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (USD) |
|---|---|
| 31,783,000 | |
| 35,221,000 | |
| 37,059,000 | |
| 42,035,000 | |
| 43,524,000 | |
| 43,999,000 | |
| 43,920,000 | |
| 32,832,000 | |
| 31,900,000 | |
| 30,813,000 | |
| 29,476,000 | |
| 29,476,000 | |
| 26,837,000 | |
| 23,961,000 | |
| 21,316,000 | |
| 28,353,000 | |
| 20,676,000 | |
| 13,307,000 | |
| 14,937,000 | |
| 13,970,000 | |
| 18,017,000 | |
| 22,506,000 | |
| 18,567,000 | |
| 15,856,000 | |
| 14,502,000 | |
| 14,152,000 | |
| 13,371,000 | |
| 12,833,000 | |
| 12,752,000 | |
| 11,399,000 | |
| 13,601,000 | |
| 12,328,000 | |
| 10,417,000 | |
| 7,793,000 | |
| 2,510,000 | |
| 1,893,000 | |
| 1,997,000 | |
| 2,522,000 | |
| 2,909,000 | |
| 2,426,000 | |
| 1,995,000 | |
| 1,502,000 | |
| 2,380,000 | |
| 1,755,000 | |
| 1,554,000 | |
| 1,362,000 | |
| 0 | |
| 180,000 |